Analytical Validation of MyProstateScore 2.0
<b>Background/Objectives</b>: Prostate cancer (PCa) is a leading cause of cancer-related deaths among men, with early detection playing a crucial role in improving outcomes. MyProstateScore 2.0 (MPS2), a novel urinary biomarker test, predicts clinically significant PCa to reduce invasive...
Saved in:
| Main Authors: | Jacob I. Meyers, Tabea M. Schatz, Cameron J. Seitz, Rachel Botbyl, Bradley S. Moore, Bill G. Crafts, John R. Kitchen, Spencer Heaton |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-04-01
|
| Series: | Diagnostics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2075-4418/15/7/923 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Urinary Markers for Prostate Cancer: State of the Art
by: Carlo Giorgio Costi, et al.
Published: (2025-05-01) -
Prostatic artery embolization in treatment of benign prostatic hyperplasia: outcome and efficacy in medium-sized compared to large prostates
by: Noha Elghitany, et al.
Published: (2025-06-01) -
Thermo-expandable intraprostatic nitinol stents in the treatment of bladder outlet obstruction: a consecutive case series
by: Albert Arch, et al.
Published: (2024-10-01) -
Prostate Artery Embolization in Patients above Eighty Years Old: Clinical Efficacy and Safety
by: Hossam Saro, et al.
Published: (2022-07-01) -
Prostatic Artery Embolization for Benign Prostatic Hyperplasia—A Primer for Interventional Radiologists
by: Tiago Bilhim, et al.
Published: (2021-07-01)